Wealth Enhancement Advisory Services
TXG icon

Wealth Enhancement Advisory Services’s 10x Genomics TXG Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.48M Buy
159,113
+6,926
+5% +$182K 0.01% 864
2026
Q1 		$3.4M Buy
152,187
+33,481
+28% +$669K 0.01% 1104
2025
Q4 		$2.29M Buy
118,706
+17,763
+18% +$268K ﹤0.01% 1443
2025
Q3 		$1.17M Buy
100,943
+4,942
+5% +$64.4K ﹤0.01% 1755
2025
Q2 		$1.25M Buy
96,001
+64,940
+209% +$592K ﹤0.01% 1622
2025
Q1 		$271K Buy
31,061
+2,564
+9% +$32.3K ﹤0.01% 2527
2024
Q4 		$409K Buy
28,497
+4,545
+19% +$71.7K ﹤0.01% 2137
2024
Q3 		$541K Buy
23,952
+10,935
+84% +$226K ﹤0.01% 1780
2024
Q2 		$253K Buy
13,017
+176
+1% +$4.61K ﹤0.01% 2109
2024
Q1 		$482K Sell
12,841
-7,559
-37% -$332K ﹤0.01% 1609
2023
Q4 		$1.14M Buy
20,400
+111
+0.5% +$4.83K ﹤0.01% 1116
2023
Q3 		$837K Buy
+20,289
New +$1.06M ﹤0.01% 1173

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wealth Enhancement Advisory Services's TXG Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its 10x Genomics (TXG) stake by 4.6% in Q2 2026, buying an estimated $182K and bringing the position to 159,113 shares worth $6.48M. The position accounts for 0.01% of the portfolio, ranked #864.

Wealth Enhancement Advisory Services first reported a position in TXG in Q3 2023 and has held it in 12 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Wealth Enhancement Advisory Services held 159,113 shares of 10x Genomics worth $6.48M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 6,926 10x Genomics shares in Q2 2026, an estimated $182K.
  • 10x Genomics made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #864 holding.
  • Wealth Enhancement Advisory Services first reported a position in 10x Genomics in Q3 2023 and has held it in 12 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.